a76df2f9_docrine_Cancer_Research___CFCF__Status
[Title] A Phase II Study Evaluating the Efficacy and Safety of Ultratrace Iobenguane I 131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma [Phase] II [Conditions] Pheochromocytoma [State] CA FL IA LA MD MO NY NC PA RI TX [Status] 
Not Recruiting
N o t R e c r u i t i n g
E n r o l l i n g
Clinical Trials Finder | Carcinoid and Pancreatic Neuroendocrine Cancer Research | CFCF
Status